To investigate whether CD326− CD44+ adherent fibroblasts express mesenchyme-derived surface markers, we performed immunophenotypic characterization of the monolayer generated in breast tumor fragment cultures after 3 weeks by flow cytometry. The gene discussed is CD44; the disease is breast neoplasm.